Home » Topics » Regulatory » Patents

Patents
RSS

Boehringer Ingelheim Pharma patents AMPK activators

Aug. 4, 2016

Merck & Co. develops factor XIa inhibitors

Aug. 4, 2016

University of Occupational and Environmental Health and Yakult Honsha disclose ZNF143 inhibitors

Aug. 3, 2016

Novartis patents angiotensin receptor antagonists

Aug. 3, 2016

University of California, Oakland describes heat schock protein inhibitors

Aug. 2, 2016

Janssen Pharmaceutica introduces cannabinoid CB1 inverse agonists

Aug. 2, 2016

Korea Research Institute of Bioscience and Biotechnology discloses antibiotic compounds

Aug. 2, 2016

Bayer Healthcare patents chemokine receptor antagonists

Aug. 2, 2016

The Vanderbilt University reports mGlu4 receptor PAMs

Aug. 2, 2016

Chengdu Bestchiralbio introduces LDL-receptor expression enhancers

Aug. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026